These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1535655)

  • 1. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition.
    Tan LB; Brilla C; Weber KT
    J Hypertens Suppl; 1992 Apr; 10(1):S31-4. PubMed ID: 1535655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure.
    Brilla CG
    Curr Opin Cardiol; 1994 Jul; 9 Suppl 1():S2-10; discussion S10-1. PubMed ID: 7827369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
    Brilla CG; Janicki JS; Weber KT
    Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioreparation with lisinopril in the management of hypertension and heart failure.
    Weber KT; Brilla CG; Janicki JS
    Cardiology; 1991; 79 Suppl 1():62-73. PubMed ID: 1655265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease].
    Funck RC; Wilke A; Rupp H; Maisch B; Brilla CG
    Herz; 1995 Oct; 20(5):330-9. PubMed ID: 7498880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension.
    Matsubara BB; Matsubara LS; Franco M; Padovani JC; Janicki JS
    Int J Exp Pathol; 1999 Apr; 80(2):97-104. PubMed ID: 10469264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
    Farina NK; Johnston CI; Burrell LM
    J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.
    Brilla CG; Janicki JS; Weber KT
    Circ Res; 1991 Jul; 69(1):107-15. PubMed ID: 1647274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure.
    Michel JB
    Eur Heart J; 1990 May; 11 Suppl D():17-26. PubMed ID: 2141818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
    Kabour A; Henegar JR; Devineni VR; Janicki JS
    Cardiovasc Res; 1995 Apr; 29(4):543-8. PubMed ID: 7796449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypertensive heart disease with ACE inhibitors.
    Stumpe KO
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S166-71. PubMed ID: 2485024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action.
    Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ
    Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
    Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA
    J Pharm Pharmacol; 2016 Nov; 68(11):1422-1429. PubMed ID: 27670145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.